» Articles » PMID: 38218934

Whole-orbit Radiomics: Machine Learning-based Multi- and Fused- Region Radiomics Signatures for Intravenous Glucocorticoid Response Prediction in Thyroid Eye Disease

Abstract

Background: Radiomics analysis of orbital magnetic resonance imaging (MRI) shows preliminary potential for intravenous glucocorticoid (IVGC) response prediction of thyroid eye disease (TED). The current region of interest segmentation contains only a single organ as extraocular muscles (EOMs). It would be of great value to consider all orbital soft tissues and construct a better prediction model.

Methods: In this retrospective study, we enrolled 127 patients with TED that received 4·5 g IVGC therapy and had complete follow-up examinations. Pre-treatment orbital T2-weighted imaging (T2WI) was acquired for all subjects. Using multi-organ segmentation (MOS) strategy, we contoured the EOMs, lacrimal gland (LG), orbital fat (OF), and optic nerve (ON), respectively. By fused-organ segmentation (FOS), we contoured the aforementioned structures as a cohesive unit. Whole-orbit radiomics (WOR) models consisting of a multi-regional radiomics (MRR) model and a fused-regional radiomics (FRR) model were further constructed using six machine learning (ML) algorithms.

Results: The support vector machine (SVM) classifier had the best performance on the MRR model (AUC = 0·961). The MRR model outperformed the single-regional radiomics (SRR) models (highest AUC = 0·766, XGBoost on EOMs, or LR on OF) and conventional semiquantitative imaging model (highest AUC = 0·760, NaiveBayes). The application of different ML algorithms for the comparison between the MRR model and the FRR model (highest AUC = 0·916, LR) led to different conclusions.

Conclusions: The WOR models achieved a satisfactory result in IVGC response prediction of TED. It would be beneficial to include more orbital structures and implement ML algorithms while constructing radiomics models. The selection of separate or overall segmentation of orbital soft tissues has not yet attained its final optimal result.

Citing Articles

Advances in artificial intelligence in thyroid-associated ophthalmopathy.

Yi C, Niu G, Zhang Y, Rao J, Liu G, Yang W Front Endocrinol (Lausanne). 2024; 15:1356055.

PMID: 38715793 PMC: 11075148. DOI: 10.3389/fendo.2024.1356055.


Whole-orbit-based multiparametric assessment of disease activity of thyroid eye disease on Dixon MRI.

Xia D, Zhang H, Wang H, Jiang M, Tang Y, Li Y Int Ophthalmol. 2024; 44(1):213.

PMID: 38700596 DOI: 10.1007/s10792-024-03138-1.

References
1.
Hu H, Chen L, Zhang J, Chen W, Chen H, Liu H . T -Weighted MR Imaging-Derived Radiomics for Pretreatment Determination of Therapeutic Response to Glucocorticoid in Patients With Thyroid-Associated Ophthalmopathy: Comparison With Semiquantitative Evaluation. J Magn Reson Imaging. 2022; 56(3):862-872. DOI: 10.1002/jmri.28088. View

2.
Duron L, Heraud A, Charbonneau F, Zmuda M, Savatovsky J, Fournier L . A Magnetic Resonance Imaging Radiomics Signature to Distinguish Benign From Malignant Orbital Lesions. Invest Radiol. 2020; 56(3):173-180. DOI: 10.1097/RLI.0000000000000722. View

3.
Vandewalle J, Luypaert A, De Bosscher K, Libert C . Therapeutic Mechanisms of Glucocorticoids. Trends Endocrinol Metab. 2017; 29(1):42-54. DOI: 10.1016/j.tem.2017.10.010. View

4.
Hu H, Xu X, Chen L, Chen W, Wu Q, Chen H . Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues. Endocrine. 2020; 70(2):372-379. DOI: 10.1007/s12020-020-02367-5. View

5.
Zhou M, Shen L, Jiao Q, Ye L, Zhou Y, Zhu W . ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION. Endocr Pract. 2019; 25(12):1268-1278. DOI: 10.4158/EP-2019-0133. View